These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 32508223)
1. Clinical utility of genomic DNA Q-PCR for the monitoring of a patient with atypical e19a2 Pagani IS; Dang P; Saunders VA; Braley J; Thieleke A; Branford S; Hughes TP; Ross DM Leuk Lymphoma; 2020 Oct; 61(10):2527-2529. PubMed ID: 32508223 [No Abstract] [Full Text] [Related]
2. Concurrence of e1a2 and e19a2 BCR-ABL1 Fusion Transcripts in a Typical Case of Chronic Myeloid Leukemia. Lee J; Kim DS; Lee HS; Choi SI; Cho YG Ann Lab Med; 2017 Jan; 37(1):74-76. PubMed ID: 27834071 [No Abstract] [Full Text] [Related]
3. [A clinical and laboratory study of chronic myeloid leukemia with atypical BCR-ABL fusion gene subtypes]. Gui X; Pan J; Qiu H; Cen J; Xue Y; Chen S; Shen H; Yao L; Zhang J; Wu Y; Chen Y Zhonghua Xue Ye Xue Za Zhi; 2014 Mar; 35(3):210-4. PubMed ID: 24666486 [TBL] [Abstract][Full Text] [Related]
4. Development of an inverse-PCR approach for characterization of the major Gutiérrez LG; Abelleyro MM; Ruiz MS; Anchordoqui MS; Freitas J; Bianchini M; De Brasi CD; Larripa IB Clin Chem Lab Med; 2021 Nov; 59(12):e449-e453. PubMed ID: 34162038 [No Abstract] [Full Text] [Related]
5. Prevalence and outcomes of uncommon BCR-ABL1 fusion transcripts in patients with chronic myeloid leukaemia: data from a single centre. Qin YZ; Jiang Q; Jiang H; Lai YY; Shi HX; Chen WM; Yu L; Huang XJ Br J Haematol; 2018 Sep; 182(5):693-700. PubMed ID: 29974949 [TBL] [Abstract][Full Text] [Related]
6. Identification of e19a2 BCR-ABL fusions (mu-BCR breakpoints) at the DNA level by ligation-mediated PCR. Boeckx N; Jansen MW; Haskovec C; Vandenberghe P; van der Velden VH; van Dongen JJ Leukemia; 2005 Jul; 19(7):1292-5. PubMed ID: 15843824 [No Abstract] [Full Text] [Related]
7. Chronic myeloid leukemia with a rare fusion transcript, e19a2 BCR-ABL1: A report of three cases from India. Sazawal S; Chikkara S; Singh K; Chaubey R; Chandra D; Mishra P; Mahapatra M; Seth T; Saxena R Ann Diagn Pathol; 2017 Apr; 27():24-27. PubMed ID: 28325357 [TBL] [Abstract][Full Text] [Related]
8. E255K and G250E mutation appearing in a patient with e19a2 chronic myeloid leukemia resistant to imatinib. Li C; Wang Y; Xu D; Zhang P; Ding X; Zhang N; Xiao M; Huang L; Meng L Clin Lab; 2015; 61(1-2):183-6. PubMed ID: 25807654 [TBL] [Abstract][Full Text] [Related]
9. A multiplex PCR for improved detection of typical and atypical BCR-ABL fusion transcripts. Burmeister T; Reinhardt R Leuk Res; 2008 Apr; 32(4):579-85. PubMed ID: 17928051 [TBL] [Abstract][Full Text] [Related]
10. Clinical characteristics and prognostic significance of chronic myeloid leukemia with rare BCR-ABL1 transcripts. Xue M; Wang Q; Huo L; Wen L; Yang X; Wu Q; Pan J; Cen J; Ruan C; Wu D; Chen S Leuk Lymphoma; 2019 Dec; 60(12):3051-3057. PubMed ID: 31258010 [TBL] [Abstract][Full Text] [Related]
11. The first report of chronic myelogenous leukemia with e19a2 micro-BCR/ABL1 presenting with massive myelofibrosis. Kim HY; Park S; Kim SH; Kim HJ Blood Cells Mol Dis; 2017 Jun; 65():68-70. PubMed ID: 28571780 [No Abstract] [Full Text] [Related]
15. Standardized Molecular Monitoring for Variant BCR-ABL1 Transcripts in Chronic Myeloid Leukemia. Langabeer SE Arch Pathol Lab Med; 2015 Aug; 139(8):969. PubMed ID: 26230589 [No Abstract] [Full Text] [Related]
16. [Atypical BCR-ABL transcripts in patients with chronic myeloid leukemia--the scheme for the diagnosis and monitoring of minimal residual disease]. Link-Lenczowska D; Sacha T; Zawada M; Czekalska S; Florek I; Skotnicki AB Przegl Lek; 2014; 71(5):258-62. PubMed ID: 25248240 [TBL] [Abstract][Full Text] [Related]
17. Characterization of a novel variant BCR-ABL1 fusion transcript in a patient with chronic myeloid leukemia: Implications for molecular monitoring. Crampe M; Haslam K; Kelly J; Conneally E; Langabeer SE Hematol Oncol Stem Cell Ther; 2017 Jun; 10(2):85-88. PubMed ID: 27013275 [TBL] [Abstract][Full Text] [Related]
18. E355G mutation appearing in a patient with e19a2 chronic myeloid leukaemia resistant to imatinib. Bennour A; Beaufils N; Sennana H; Meddeb B; Saad A; Gabert J J Clin Pathol; 2010 Aug; 63(8):737-40. PubMed ID: 20702476 [TBL] [Abstract][Full Text] [Related]
19. Analytical Validation of a Highly Sensitive, Multiplexed Chronic Myeloid Leukemia Monitoring System Targeting BCR-ABL1 RNA. Brown JT; Beldorth IJ; Laosinchai-Wolf W; Fahey ME; Jefferson KL; Ruskin AK; Roth JJ; Cai L; Watt CD; Press RD; Yang F; Hedges JB; Andruss BF J Mol Diagn; 2019 Jul; 21(4):718-733. PubMed ID: 31026597 [TBL] [Abstract][Full Text] [Related]
20. The Q-LAMP Method Represents a Valid and Rapid Alternative for the Detection of the Stella S; Gottardi EM; Favout V; Barragan Gonzalez E; Errichiello S; Vitale SR; Fava C; Luciano L; Stagno F; Grimaldi F; Pironi L; Sargas Simarro C; Vigneri P; Izzo B Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31817063 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]